Posted inComunicati
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE NINGBO, China, June 22, 2026 /PRNewswire/ -- TrueLab Biopharmaceutical, an…
Continue Reading














